Related references
Note: Only part of the references are listed.Novel and emerging treatments for major depression
Steven Marwaha et al.
LANCET (2023)
Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries et al.
MOLECULAR PSYCHIATRY (2023)
Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
Hyebin Choi et al.
DIAGNOSTICS (2021)
Serum proteomic analysis of major depressive disorder patients and their remission status: Novel biomarker set of zinc-alpha-2-glycoprotein and keratin type II cytoskeletal 1
Hyebin Choi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study
Romain Colle et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis
Kenneth McDonald et al.
SCIENTIFIC REPORTS (2020)
Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease
Patricia B. Maguire et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?
Emmanuel Jesulola et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future
Ashley L. Comes et al.
TRANSLATIONAL PSYCHIATRY (2018)
Seeking an objective diagnosis of depression
John A. Bilello
BIOMARKERS IN MEDICINE (2016)
Serum biomarkers predictive of depressive episodes in panic disorder
M. G. Gottschalk et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
iTRAQ TECHNOLOGY-BASED IDENTIFICATION OF HUMAN PERIPHERAL SERUM PROTEINS ASSOCIATED WITH DEPRESSION
Q. Wang et al.
NEUROSCIENCE (2016)
Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses
Jiyeong Lee et al.
PSYCHIATRY INVESTIGATION (2015)
Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease
Yanjia Chen et al.
SCIENTIFIC REPORTS (2015)
A Deficit in Peripheral Serotonin Levels in Major Depressive Disorder but Not in Chronic Widespread Pain
Emilie Paul-Savoie et al.
CLINICAL JOURNAL OF PAIN (2011)
Not as golden as standards should be: Interpretation of the Hamilton Rating Scale for Depression
Levente Kriston et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Heath D. Schmidt et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49 years
Goran Trajkovic et al.
PSYCHIATRY RESEARCH (2011)
Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer
Martha E. Arellano-Garcia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
The Hamilton depression rating scale: Has the gold standard become a lead weight?
RM Bagby et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
The influence of selective serotonin reuptake inhibitors on human platelet serotonin
E Maurer-Spurej et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Share Paper
